DRKS00033224尚未招募不适用
Management of spinal hemangioblastoma - MOSH
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Adult patients treated for spinal hemangioblastoma from January 1980 to December 2023.
排除标准
- •Patient age <18 years at the time of treatment of spinal hemangioblastoma.
- •Data not analyzable.
研究者
相似试验
已完成
不适用
Medical management of CNS hemangioblastoma in pediatric patients with von Hippel-Lindau (VHL) diseaseD48.1Q85.8Connective and other soft tissueOther phakomatoses, not elsewhere classifiedDRKS00029553niversitätsklinikum Freiburg99
已完成
不适用
Minimally invasive resection of spinal hemnagioblastomasQ85.8D33.4Other phakomatoses, not elsewhere classifiedSpinal cordDRKS00010284eurochirurgieUniklinikum Freiburg18
Unknown
4 期
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal HemangiomaSpinal TumorSpinal HemangiomaBeta Blocker ToxicityNCT05106179Center for Vascular Pathology, Moscow1,000
已完成
不适用
Hemangiol, Post Marketing Surveillance StudyInfantile HemangiomaNCT04105517University Hospital, Montpellier500
进行中（未招募）
不适用
Tratamiento de los hemangiomas de la infancia con imiquimod tópico al 5%EUCTR2004-001262-40-ESInvestigador del estudio: Dr. Agustín Alomar Muntañola